Literature DB >> 6858558

Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand.

D Berg, R Sonsalla, E Kuss.   

Abstract

A radioimmunoassay has been developed for the measurement of 2-methoxyoestrogens in samples of human serum without chromatography after solvent extraction. Antibodies raised against 2-methoxyoestradiol-17 beta-hemi-succinyl-BSA served as binding protein and 2-methoxyoestrone-17-cmo-[125I]iodohistamine served as 125I-labelled ligand. A specific (little or no cross-reactivities to other oestrogens), sensitive (2.4 +/- 0.9 pg/tube) and precise (6.5% intra-assay; 9.1% inter-assay) assay was obtained by employing the heterologous bridge system. The following concentrations were found in serum samples of healthy subjects (median, range in parentheses): men (19-58 years): less than 10.3 (less than 10.3-35.5) pg/ml (n = 22); women follicular phase: 46 (18-63) pg/ml (n = 8); luteal phase: 70 (31-138) pg/ml (n = 8); post-menopausal women: 33 (21-76) pg/ml (n = 10); pregnant women 11th-16th week: 674 (216-1678) pg/ml (n = 46); 37th-40th week: 3768 (2035-10691) pg/ml (n = 34); newborn cord serum 1608 (575-3095) pg/ml (n = 41).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6858558     DOI: 10.1530/acta.0.1030282

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  27 in total

1.  Fluoroenzymatic cycling assay (FECA) for the determination of catechol estrogen monomethyl ethers in human urine.

Authors:  T Fotsis; H P Shah; M Härkönen; H Adlercreutz
Journal:  Neurochem Res       Date:  1987-06       Impact factor: 3.996

2.  Urinary excretion of catecholestrogens, 2-methoxy-estrogens and "classical estrogens" throughout the normal menstrual cycle.

Authors:  F D Berg; E Kuss
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

3.  Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine.

Authors:  Sandhya K Nair; Arti Verma; T J Thomas; T C Chou; Michael A Gallo; Akira Shirahata; Thresia Thomas
Journal:  Cancer Lett       Date:  2006-12-20       Impact factor: 8.679

Review 4.  Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.

Authors:  Svetlana Verenich; Phillip M Gerk
Journal:  Mol Pharm       Date:  2010-10-21       Impact factor: 4.939

5.  Neuronal Nitric Oxide Synthase-Mediated Genotoxicity of 2-Methoxyestradiol in Hippocampal HT22 Cell Line.

Authors:  Magdalena Gorska; Michal A Zmijewski; Alicja Kuban-Jankowska; Maciej Wnuk; Iwona Rzeszutek; Michal Wozniak
Journal:  Mol Neurobiol       Date:  2015-09-17       Impact factor: 5.590

Review 6.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

7.  2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.

Authors:  R J D'Amato; C M Lin; E Flynn; J Folkman; E Hamel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions.

Authors:  Soo Bong Lee; Amy P Wong; Keizo Kanasaki; Yong Xu; Vivek K Shenoy; Thomas F McElrath; George M Whitesides; Raghu Kalluri
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

9.  2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.

Authors:  Sara A Schaufelberger; Marinella Rosselli; Federica Barchiesi; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

10.  2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.

Authors:  Gordon S Duncan; Dirk Brenner; Michael W Tusche; Anne Brüstle; Christiane B Knobbe; Andrew J Elia; Thomas Mock; Mark R Bray; Peter H Krammer; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.